CONFIRM: Fantastic presentation by our very own Prof Fennell. Pleural or peritoneal. Max 12m of therapy. PDL1+ in 29-37% which is a bit lower than I've heard. #WCLC20 #mesothelioma
CONFIRM: Fantastic presentation by our very own Prof Fennell. Pleural or peritoneal. Max 12m of therapy. PDL1+ in 29-37% which is a bit lower than I've heard. #WCLC20 #mesothelioma
CONFIRM: Fantastic presentation by our very own Prof Fennell. Pleural or peritoneal. Max 12m of therapy. PDL1+ in 29-37% which is a bit lower than I've heard. #WCLC20 #mesothelioma
CONFIRM: Fantastic presentation by our very own Prof Fennell. Pleural or peritoneal. Max 12m of therapy. PDL1+ in 29-37% which is a bit lower than I've heard. #WCLC20 #mesothelioma
CONFIRM: Fantastic presentation by our very own Prof Fennell. Pleural or peritoneal. Max 12m of therapy. PDL1+ in 29-37% which is a bit lower than I've heard. #WCLC20 #mesothelioma
importantly PDL1 expression was not predictive of benefit
Clear benefit in epithelioid. Numbers probably too small in non-epith
I agree with the conclusions. Great presentation Dean. Fantastic to see the UK continue to lead in key #mesothelioma trials. Very exciting and can't wait to see the 1st line chemoIO data from down under.
Excellent discussion by Hui from Sydney.
Slide from discussion.
You can follow @DrRiyazShah.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.